MicroRNAs and esophageal squamous cell carcinoma

Digestion

Volumn 82, Issue 3, 2010, Pages 138-144

  Matsushima, Kayoko ^a   Isomoto, Hajime ^a   Kohno, Shigeru ^a   Nakao, Kazuhiko ^a  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Epithelial mesenchymal transition; Esophageal cancer; Esophageal squamous cell carcinoma; MicroRNA; miR 10a; miR 200 family; miR 205

Indexed keywords

MICRORNA; MIRN10 MICRORNA, HUMAN; MIRN205 MICRORNA, HUMAN;

CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; ESOPHAGUS TUMOR; HUMAN; METABOLISM; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PHYSIOLOGICAL PROCESSES; ESOPHAGEAL NEOPLASMS; HUMANS; MICRORNAS;

EID: 77954235741     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000310918     Document Type: Conference Paper

References (30)

1. Mathe EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, Schetter AJ, Braun R, Reimers M, Kumamoto K, Hughes D, Altorki NK, Casson AG, Liu CG, Wang XW, Yanaihara N, Hagiwara N, Dannenberg AJ, Miyashita M, Croce CM, Harris CC: MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 2009; 15: 6192-6200.
2. Fareed KR, Kaye P, Soomro IN, Ilyas M, Martin S, Parsons SL, Madhusudan S: Biomarkers of response to therapy in oesophago- gastric cancer. Gut 2009; 58: 127-143.
3. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, Lebanony D, Goren Y, Silberschein E, Targan N, Ben-Ari A, Gilad S, Sion-Vardy N, Tobar A, Feinmesser M, Kharenko O, Nativ O, Nass D, Perelman M, Yosepovich A, Shalmon B, Polak-Charcon S, Fridman E, Avniel A, Bentwich I, Bentwich Z, Cohen D, Chajut A, Barshack I: MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 2008; 26: 462-469.
4. Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10: 704-714.
5. Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, Swanson SJ, Godfrey TE, Litle VR: MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 2008; 135: 255-260.
6. Ogawa R, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Katada T, Harata K, Tanaka T, Fujii Y: Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med Mol Morphol 2009; 42: 102-109.
7. Lee KH, Goan YG, Hsiao M, Lee CH, Jian SH, Lin JT, Chen YL, Lu PJ: MicroRNA-373 (miR- 373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2), and stimulates proliferation in human esophageal cancer. Exp Cell Res 2009; 315: 2529-2538.
8. Hiyoshi Y, Kamohara H, Karashima R, Sato N, Imamura Y, Nagai Y, Yoshida N, Toyama E, Hayashi N, Watanabe M, Baba H: Micro- RNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 2009; 15: 1915-1922.
9. Guo Y, Chen Z, Zhang L, Zhou F, Shi S, Feng X, Li B, Meng X, Ma X, Luo M, Shao K, Li N, Qiu B, Mitchelson K, Cheng J, He J: Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008; 68: 26-33.
10. Gandellini P, Folini M, Longoni N, Pennati M, Binda M, Colecchia M, Salvioni R, Supino R, Moretti R, Limonta P, Valdagni R, Daidone MG, Zaffaroni N: miR-205 exerts tumor- suppressive functions in human prostate through down-regulation of protein kinase C. Cancer Res 2009; 69: 2287-2295.
11. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew- Goodall Y, Goodall GJ: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601.
12. Korpal M, Lee ES, Hu G, Kang Y: The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008; 283: 14910-14914.
13. Gregory PA, Bracken CP, Bert AG, Goodall GJ: MicroRNAs as regulators of epithelialmesenchymal transition. Cell Cycle 2008; 7: 3112-3118.
14. Thiery JP, Sleeman JP: Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-142.
15. Childs G, Fazzari M, Kung G, Kawachi N, Brandwein-Gensler M, McLemore M, Chen Q, Burk RD, Smith RV, Prystowsky MB, Belbin TJ, Schlecht NF: Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 2009; 174: 736-745.
16. Tran N, McLean T, Zhang X, Zhao CJ, Thomson JM, O'Brien C, Rose B: MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 2007; 358: 12-17.
17. Wu H, Mo YY: Targeting miR-205 in breast cancer. Expert Opin Ther Targets 2009; 13: 1439-1448.
18. Ryan DG, Oliveira-Fernandes M, Lavker RM: MicroRNAs of the mammalian eye display distinct and overlapping tissue specificity. Mol Vis 2006; 12: 1175-1184.
19. Fletcher AM, Heaford AC, Trask DK: Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific miR-205. Transl Oncol 2008; 1: 202-208.
20. Ason B, Darnell DK, Wittbrodt B, Berezikov E, Kloosterman WP, Wittbrodt J, Antin PB, Plasterk RH: Differences in vertebrate microRNA expression. Proc Natl Acad Sci USA 2006; 103: 14385-14389.
21. Shingara J, Keiger K, Shelton J, Laosinchai- Wolf W, Powers P, Conrad R, Brown D, Labourier E: An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA 2005; 11: 1461-1470.
22. Iorio MV, Casalini P, Piovan C, Di Leva G, Merlo A, Triulzi T, Menard S, Croce CM, Tagliabue E: MicroRNA-205 regulates HER3 in human breast cancer. Cancer Res 2009; 69: 2195-2200.
23. Wu H, Zhu S, Mo YY: Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res 2009; 19: 439-448.
24. Song H, Bu G: MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1. Biochem Biophys Res Commun 2009; 388: 400-405.
25. Shen YL, Jiang YG, Greenlee AR, Zhou LL, Liu LH: MicroRNA expression profiles and miR-10a target in anti-benzo[a]pyrene-7,8-diol- 9,10-epoxide-transformed human 16HBE cells. Biomed Environ Sci 2009; 22: 14-21.
26. Weiss FU, Marques IJ, Woltering JM, Vlecken DH, Aghdassi A, Partecke LI, Heidecke CD, Lerch MM, Bagowski CP: Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology 2009; 137: 2136-2145.
27. Tan Y, Zhang B, Wu T, Skogerbo G, Zhu X, Guo X, He S, Chen R: Transcriptional inhibition of Hoxd4 expression by miRNA-10a in human breast cancer cells. BMC Mol Biol 2009; 10: 12.
28. Han L, Witmer PD, Casey E, Valle D, Sukumar S: DNA methylation regulates micro- RNA expression. Cancer Biol Ther 2007; 6: 1284-1288.
29. Wong TS, Liu XB, Chung-Wai Ho A, Po- Wing Yuen A, Wai-Man Ng R, Ignace Wei W: Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int J Cancer 2008; 123: 251-257.
30. Osaki M, Takeshita F, Ochiya T: MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers 2008; 13: 658-670.